# The Value of Advanced MR Imaging in Gynecological Tumors and Benign Uterine Fibroids

> **NCT03993210** · NA · TERMINATED · sponsor: **Dana-Farber Cancer Institute** · enrollment: 1 (actual)

## Conditions studied

- Gynecologic Tumor

## Interventions

- **DEVICE:** Magnetic Resonance Fingerprinting (MRF)
- **DEVICE:** Q-space Trajectory Imaging (QTI)
- **DEVICE:** Magnetic Resonance Imaging Machine (MRI)

## Key facts

- **NCT ID:** NCT03993210
- **Lead sponsor:** Dana-Farber Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-09-18
- **Primary completion:** 2019-09-19
- **Final completion:** 2019-09-19
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Key personnel moving out
- **Last updated:** 2020-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03993210

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03993210, "The Value of Advanced MR Imaging in Gynecological Tumors and Benign Uterine Fibroids". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03993210. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*